Safe Orthopaedics SA (FRA:OR9)

Market Cap	127.51K -41.8%
Revenue (ttm)	5.36M -3.0%
Net Income	-4.67M
EPS	-23.46
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.4900
Previous Close	0.4900
Day's Range	0.4900 - 0.4900
52-Week Range	0.4000 - 2.0000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 9, 2026

About Safe Orthopaedics

Safe Orthopaedics SA, a medical technology company, develops and markets ready-to-use implants and sterile instrumentation for spinal surgery in France. It offers SteriSpine PS, an all-round kit for open, mini open, and MIS surgeries, as well as percutaneous kit; SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems; SteriSpine LC, a ready to use instrumentation for lumbar cage portfolio, including Cedar and Elm; and SteriSpine CC, a ready to use instrumentation for cervical cage, such as Walnut. The company was foun...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2010
• Employees: 87
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: OR9

Financial Performance

In 2025, Safe Orthopaedics's revenue was 5.36 million, an increase of 6.41% compared to the previous year's 5.04 million. Losses were -4.67 million, -99.76% less than in 2024.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 27, 2026

Data Sources Report a data error